Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TURKOVAC vs CoronaVac in Adolescents
NCT05230940Phase 2Completed
- Sponsor
- TÜSEB
- Start
- Feb 2022
- Primary completion
- May 2023
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of turkovac in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by TÜSEB. Primary endpoint: COVID-19 Positivity Rate. Started Feb 2022; status: completed.
02
Drugs
turkovac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05230940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05230940.